Literature DB >> 30508028

Association of Pallidal Neurostimulation and Outcome Predictors With X-linked Dystonia Parkinsonism.

Norbert Brüggemann1,2, Aloysius Domingo1, Dirk Rasche3, Christian K E Moll4, Raymond L Rosales5, Roland Dominic G Jamora6,7, Henrike Hanssen1,2, Alexander Münchau1, Julia Graf1,2, Anne Weissbach1, Vera Tadic1,2, Cid C Diesta8, Jens Volkmann9, Andrea Kühn10, Thomas F Münte2, Volker Tronnier3, Christine Klein1.   

Abstract

Importance: Anecdotal evidence suggests that deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in ameliorating dystonia in X-linked dystonia parkinsonism (XDP), a disease that is usually refractive to medical therapy. Objective: To determine the efficacy of GPi-DBS in a cohort of patients with XDP in a prospective study and identify predictors of postoperative outcomes. Design, Setting, and Participants: This observational prospective cohort study enrolled patients in February 2013 and was completed in December 2014. The patients were followed up for up to 46 months. Patients from the Philippines were treated in a single center in Lübeck, Germany and followed up in the Philippines. Sixteen men with XDP (mean [SD] age, 40.9 [7.3] years; disease duration, 1-6 years) from the Philippines with predominant dystonia were selected. Exposures: All patients underwent bilateral GPi-DBS in Lübeck, Germany. Main Outcomes and Measures: Clinical assessment included the motor parts of the Burke-Fahn-Marsden scale (BFMDRS-M) and the Unified Parkinson's Disease Rating Scale (UPDRS-III). T1-based basal ganglia volumetry was performed and correlated with postoperative outcomes.
Results: The study participants included 16 Filipino men (mean age, 40.9 years). Masked video ratings revealed significant improvements of dystonia severity 1 week (-55%; range, -94% to 59%; P < .01) and 6 months (-59%; range, -100% to 22%; P < .001) after surgery. The UDPRS-III score also improved, albeit to a lesser extent (-19%; range, -54% to 95%; and -27%; range, -70% to 124%; respectively). Unmasked long-term follow-up confirmed the continued efficacy of GPi-DBS up to 46 months after surgery. Important secondary end points improved, including activities of daily living, pain severity, weight, and quality of life. Caudate atrophy was a predictor of a less beneficial outcome (r = 0.817, P = .004). Conclusions and Relevance: Internal globus pallidus DBS had a positive association in XDP with predominant dystonia (the primary end point) and contributed to an improved quality of life (the secondary end point). The response to DBS occurred within 1 week. Given the inverse correlation of postoperative benefit and caudate atrophy, GPi-DBS should be considered early during the disease course. Close international collaboration, training, and funding from multiple sources enabled the sustainable follow-up of patients with XDP in the Philippines.

Entities:  

Mesh:

Year:  2019        PMID: 30508028      PMCID: PMC6439955          DOI: 10.1001/jamaneurol.2018.3777

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  16 in total

Review 1.  Oral pharmacological treatment of X-linked dystonia parkinsonism: successes and failures.

Authors:  Roland Dominic G Jamora; Cid Czarina E Diesta; Paul Matthew D Pasco; Lillian V Lee
Journal:  Int J Neurosci       Date:  2011-01-19       Impact factor: 2.292

2.  Neuroanatomical changes extend beyond striatal atrophy in X-linked dystonia parkinsonism.

Authors:  Norbert Brüggemann; Marcus Heldmann; Christine Klein; Aloysius Domingo; Dirk Rasche; Volker Tronnier; Raymond L Rosales; Roland Dominic G Jamora; Lillian V Lee; Thomas F Münte
Journal:  Parkinsonism Relat Disord       Date:  2016-07-26       Impact factor: 4.891

3.  Evidence of TAF1 dysfunction in peripheral models of X-linked dystonia-parkinsonism.

Authors:  Aloysius Domingo; David Amar; Karen Grütz; Lillian V Lee; Raymond Rosales; Norbert Brüggemann; Roland Dominic Jamora; Eva Cutiongco-Dela Paz; Arndt Rolfs; Dirk Dressler; Uwe Walter; Dimitri Krainc; Katja Lohmann; Ron Shamir; Christine Klein; Ana Westenberger
Journal:  Cell Mol Life Sci       Date:  2016-02-15       Impact factor: 9.261

4.  Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration.

Authors:  Ioannis U Isaias; Jens Volkmann; Andreas Kupsch; Jean-Marc Burgunder; Jill L Ostrem; Ron L Alterman; Hubertus Maximilian Mehdorn; Thomas Schönecker; Joachim K Krauss; Philip Starr; Rene Reese; Andrea A Kühn; W M Michael Schüpbach; Michele Tagliati
Journal:  J Neurol       Date:  2011-03-02       Impact factor: 4.849

5.  Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes.

Authors:  Caroline Andrews; Iciar Aviles-Olmos; Marwan Hariz; Thomas Foltynie
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-14       Impact factor: 10.154

Review 6.  Neuropsychological, neuropsychiatric, and quality of life issues in DBS for dystonia.

Authors:  Marjan Jahanshahi; Virginie Czernecki; And Mateusz Zurowski
Journal:  Mov Disord       Date:  2011-06       Impact factor: 10.338

7.  Pallidal deep-brain stimulation in primary generalized or segmental dystonia.

Authors:  Andreas Kupsch; Reiner Benecke; Jörg Müller; Thomas Trottenberg; Gerd-Helge Schneider; Werner Poewe; Wilhelm Eisner; Alexander Wolters; Jan-Uwe Müller; Günther Deuschl; Marcus O Pinsker; Inger Marie Skogseid; Geir Ketil Roeste; Juliane Vollmer-Haase; Angela Brentrup; Martin Krause; Volker Tronnier; Alfons Schnitzler; Jürgen Voges; Guido Nikkhah; Jan Vesper; Markus Naumann; Jens Volkmann
Journal:  N Engl J Med       Date:  2006-11-09       Impact factor: 91.245

8.  Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism.

Authors:  Satoshi Goto; Toshitaka Kawarai; Ryoma Morigaki; Shinya Okita; Hidetaka Koizumi; Shinji Nagahiro; Edwin L Munoz; Lillian V Lee; Ryuji Kaji
Journal:  Brain       Date:  2013-04-18       Impact factor: 13.501

9.  Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.

Authors:  Tatsiana Aneichyk; William T Hendriks; Rachita Yadav; David Shin; Dadi Gao; Christine A Vaine; Ryan L Collins; Aloysius Domingo; Benjamin Currall; Alexei Stortchevoi; Trisha Multhaupt-Buell; Ellen B Penney; Lilian Cruz; Jyotsna Dhakal; Harrison Brand; Carrie Hanscom; Caroline Antolik; Marisela Dy; Ashok Ragavendran; Jason Underwood; Stuart Cantsilieris; Katherine M Munson; Evan E Eichler; Patrick Acuña; Criscely Go; R Dominic G Jamora; Raymond L Rosales; Deanna M Church; Stephen R Williams; Sarah Garcia; Christine Klein; Ulrich Müller; Kirk C Wilhelmsen; H T Marc Timmers; Yechiam Sapir; Brian J Wainger; Daniel Henderson; Naoto Ito; Neil Weisenfeld; David Jaffe; Nutan Sharma; Xandra O Breakefield; Laurie J Ozelius; D Cristopher Bragg; Michael E Talkowski
Journal:  Cell       Date:  2018-02-22       Impact factor: 66.850

10.  Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism.

Authors:  Paul Matthew D Pasco; Roland Dominic G Jamora; Raymond L Rosales; Cid Czarina E Diesta; Arlene R Ng; Rosalia A Teleg; Criscely L Go; Lillian Lee; Hubert H Fernandez
Journal:  NPJ Parkinsons Dis       Date:  2017-07-25
View more
  10 in total

1.  Neurocognitive profile of patients with X-linked dystonia-parkinsonism.

Authors:  Roland Dominic G Jamora; Cezar Thomas R Suratos; Jesi Ellen C Bautista; Gail Melissa I Ramiro; Ana Westenberger; Christine Klein; Lourdes K Ledesma
Journal:  J Neural Transm (Vienna)       Date:  2021-02-27       Impact factor: 3.575

Review 2.  Arching deep brain stimulation in dystonia types.

Authors:  Han-Joon Kim; Beomseok Jeon
Journal:  J Neural Transm (Vienna)       Date:  2021-03-19       Impact factor: 3.575

Review 3.  X-Linked Dystonia-Parkinsonism: recent advances.

Authors:  D Cristopher Bragg; Nutan Sharma; Laurie J Ozelius
Journal:  Curr Opin Neurol       Date:  2019-08       Impact factor: 5.710

4.  Transcranial Magnetic Resonance-Guided Focused Ultrasound in X-Linked Dystonia-Parkinsonism.

Authors:  Roland Dominic G Jamora; Wei-Chieh Chang; Takaomi Taira
Journal:  Life (Basel)       Date:  2021-04-26

5.  Quality of life outcomes after deep brain stimulation in dystonia: A systematic review.

Authors:  Takashi Tsuboi; Joshua K Wong; Michael S Okun; Adolfo Ramirez-Zamora
Journal:  Parkinsonism Relat Disord       Date:  2019-11-18       Impact factor: 4.402

Review 6.  Pallidal Deep Brain Stimulation for Monogenic Dystonia: The Effect of Gene on Outcome.

Authors:  Stephen Tisch; Kishore Raj Kumar
Journal:  Front Neurol       Date:  2021-01-08       Impact factor: 4.003

Review 7.  The importance of genetic testing for dystonia patients and translational research.

Authors:  Jelena Pozojevic; Christian Beetz; Ana Westenberger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-19       Impact factor: 3.575

8.  Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat.

Authors:  Lindsey N Campion; Alan Mejia Maza; Rachita Yadav; Ellen B Penney; Micaela G Murcar; Kevin Correia; Tammy Gillis; Cara Fernandez-Cerado; M Salvie Velasco-Andrada; G Paul Legarda; Niecy G Ganza-Bautista; J Benedict B Lagarde; Patrick J Acuña; Trisha Multhaupt-Buell; Gabrielle Aldykiewicz; Melanie L Supnet; Jan K De Guzman; Criscely Go; Nutan Sharma; Edwin L Munoz; Mark C Ang; Cid Czarina E Diesta; D Cristopher Bragg; Laurie J Ozelius; Vanessa C Wheeler
Journal:  Acta Neuropathol Commun       Date:  2022-04-08       Impact factor: 7.801

Review 9.  Combined dystonias: clinical and genetic updates.

Authors:  Anne Weissbach; Gerard Saranza; Aloysius Domingo
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

Review 10.  Monogenic Parkinson's Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing.

Authors:  Fangzhi Jia; Avi Fellner; Kishore Raj Kumar
Journal:  Genes (Basel)       Date:  2022-03-07       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.